» Articles » PMID: 39707212

Osthole Ameliorates Wear Particle-induced Osteogenic Impairment by Mitigating Endoplasmic Reticulum Stress Via PERK Signaling Cascade

Overview
Journal Mol Med
Publisher Biomed Central
Date 2024 Dec 20
PMID 39707212
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Periprosthetic osteolysis and subsequent aseptic loosening are the leading causes of failure following total joint arthroplasty. Osteogenic impairment induced by wear particles is regarded as a crucial contributing factor in the development of osteolysis, with endoplasmic reticulum (ER) stress identified as a key underlying mechanism. Therefore, identifying potential therapeutic targets and agents that can regulate ER stress adaption in osteoblasts is necessary for arresting aseptic loosening. Osthole (OST), a natural coumarin derivative, has demonstrated promising osteogenic properties and the ability to modulate ER stress adaption in various diseases. However, the impact of OST on ER stress-mediated osteogenic impairment caused by wear particles remains unclear.

Methods: TiAlV particles (TiPs) were sourced from the prosthesis of patients who underwent revision hip arthroplasty due to aseptic loosening. A mouse calvarial osteolysis model was utilized to explore the effects of OST on TiPs-induced osteogenic impairment in vivo. Primary mouse osteoblasts were employed to investigate the impact of OST on ER stress-mediated osteoblast apoptosis and osteogenic inhibition induced by TiPs in vitro. The mechanisms underlying OST-modulated alleviation of ER stress induced by TiPs were elucidated through Molecular docking, immunochemistry, PCR, and Western blot analysis.

Results: In this study, we found that OST treatment effectively mitigated TiAlV particles (TiPs)-induced osteolysis by enhancing osteogenesis in a mouse calvarial model. Furthermore, we observed that OST could attenuate ER stress-mediated apoptosis and osteogenic reduction in osteoblasts exposed to TiPs in vitro and in vivo. Mechanistically, we demonstrated that OST exerts bone-sparing effects on stressed osteoblasts upon TiPs exposure by specifically suppressing the ER stress-dependent PERK signaling cascade.

Conclusion: Osthole ameliorates wear particle-induced osteogenic impairment by mitigating endoplasmic reticulum stress via PERK signaling cascade. These findings suggest that OST may serve as a potential therapeutic agent for combating wear particle-induced osteogenic impairment, offering a novel alternative strategy for managing aseptic prosthesis loosening.

References
1.
Kuo P, Hsu Y, Chang C, Chang J . Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther. 2005; 314(3):1290-9. DOI: 10.1124/jpet.105.085092. View

2.
Hetz C . The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012; 13(2):89-102. DOI: 10.1038/nrm3270. View

3.
Wang Z, Huang Z, Gan J, Liu N, Zhou G, Shi T . The fibroblast expression of RANKL in CoCrMo-particle-induced osteolysis is mediated by ER stress and XBP1s. Acta Biomater. 2015; 24:352-60. DOI: 10.1016/j.actbio.2015.06.024. View

4.
Goodman S, Gallo J . Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment. J Clin Med. 2019; 8(12). PMC: 6947309. DOI: 10.3390/jcm8122091. View

5.
Yu X, Wu Q, Ren Z, Chen B, Wang D, Yuan T . Kaempferol attenuates wear particle-induced inflammatory osteolysis via JNK and p38-MAPK signaling pathways. J Ethnopharmacol. 2023; 318(Pt B):117019. DOI: 10.1016/j.jep.2023.117019. View